Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

November 2003 (Volume 42, Supplement 3)   [Index by Author] 
 
       Introduction
       The effects of channelling bias on interpretation of observational studies
       Drug utilization and compliance
       Patient-centred issues: dyspepsia and post-operative pain
       Health economics of COX-2-specific inhibitors
       Discussion and Concluding Remarks
 
Evidence of value: assessing treatment outcomes in arthritis and pain
 



To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Introduction:

Thomas M. MacDonald
Introduction
Rheumatology 2003 42: iii1-iii2; doi:10.1093/rheumatology/keg491 [PDF]  

The effects of channelling bias on interpretation of observational studies:

T. M. MacDonald, D. Pettitt, F. H. Lee, and J. S. Schwartz
Channelling of patients taking NSAIDs or cyclooxygenase-2-specific inhibitors and its effect on interpretation of outcomes
Rheumatology 2003 42: iii3-iii10; doi:10.1093/rheumatology/keg492 [Abstract] [PDF]  

Drug utilization and compliance:

J. LeLorier, C. Fitzsimon, M. Keresteci, D. Stewart, and F. Lavoie
Drug utilization review of celecoxib in Ontario
Rheumatology 2003 42: iii11-iii16; doi:10.1093/rheumatology/keg493 [Abstract] [PDF]  

Y. Moride, T. Ducruet, S. Rochon, and F. Lavoie
Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec
Rheumatology 2003 42: iii17-iii22; doi:10.1093/rheumatology/keg494 [Abstract] [PDF]  

M. C. J. M. Sturkenboom, T. A. Burke, J. P. Dieleman, M. J. D. Tangelder, F. Lee, and J. L. Goldstein
Underutilization of preventive strategies in patients receiving NSAIDs
Rheumatology 2003 42: iii23-iii31; doi:10.1093/rheumatology/keg495 [Abstract] [PDF]  

Patient-centred issues: dyspepsia and post-operative pain:

L. Rabeneck
Measuring dyspepsia-related health in randomized trials: the Severity of Dyspepsia Assessment (SODA) and its use in treatment with NSAIDs and COX-2-specific inhibitors
Rheumatology 2003 42: iii32-iii39; doi:10.1093/rheumatology/keg496 [Abstract] [PDF]  

J. Stephens, B. Laskin, C. Pashos, B. Peña, and J. Wong
The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors
Rheumatology 2003 42: iii40-iii52; doi:10.1093/rheumatology/keg497 [Abstract] [PDF]  

Health economics of COX-2-specific inhibitors:

B. von Scheele, B. Peña, J. Wong, and L. Niculescu
Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial
Rheumatology 2003 42: iii53-iii59; doi:10.1093/rheumatology/keg498 [Abstract] [PDF]  

M. F. Drummond
The use of health economic information by reimbursement authorities
Rheumatology 2003 42: iii60-iii63; doi:10.1093/rheumatology/keg499 [Abstract] [PDF]  

Discussion and Concluding Remarks:

Thomas M. MacDonald
Discussion and Concluding Remarks
Rheumatology 2003 42: iii64-iii67; doi:10.1093/rheumatology/keg500 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.